Clinical response and remission were observed in 50% and 41% of cases, respectively, with significant reductions in the Simple Endoscopic Score for CD (SES-CD) (from 14.0 to 6.0, p = 0.0005), Crohn’s disease patient-reported outcome-2 score (PRO-2), and C-reactive protein (CRP) levels. Here, CRP is linked to Crohn disease.